Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1993 Oct 1;90(19):8856–8860. doi: 10.1073/pnas.90.19.8856

Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system.

L Roselli-Rehfuss 1, K G Mountjoy 1, L S Robbins 1, M T Mortrud 1, M J Low 1, J B Tatro 1, M L Entwistle 1, R B Simerly 1, R D Cone 1
PMCID: PMC47459  PMID: 8415620

Abstract

Corticotropin (ACTH) and melanotropin (MSH) peptides (melanocortins) are produced not only in the pituitary but also in the brain, with highest concentrations in the arcuate nucleus of the hypothalamus and the commisural nucleus of the solitary tract. We have identified a receptor for MSH and ACTH peptides that is specifically expressed in regions of the hypothalamus and limbic system. This melanocortin receptor (MC3-R) is found in neurons of the arcuate nucleus known to express proopiomelanocortin (POMC) and in a subset of the nuclei to which these neurons send projections. The MC3-R is 43% identical to the MSH receptor present in melanocytes and is strongly coupled to adenylyl cyclase. Unlike the MSH or ACTH receptors, MC3-R is potently activated by gamma-MSH peptides, POMC products that were named for their amino acid homology with alpha- and beta-MSH, but lack melanotropic activity. The primary biological role of the gamma-MSH peptides is not yet understood. The location and properties of this receptor provide a pharmacological basis for the action of POMC peptides produced in the brain and possibly a specific physiological role for gamma-MSH.

Full text

PDF
8860

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arriza J. L., Simerly R. B., Swanson L. W., Evans R. M. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron. 1988 Nov;1(9):887–900. doi: 10.1016/0896-6273(88)90136-5. [DOI] [PubMed] [Google Scholar]
  2. Bijlsma W. A., Jennekens F. G., Schotman P., Gispen W. H. Effects of corticotrophin (ACTH) on recovery of sensorimotor function in the rat: structure-activity study. Eur J Pharmacol. 1981 Nov 19;76(1):73–79. doi: 10.1016/0014-2999(81)90011-x. [DOI] [PubMed] [Google Scholar]
  3. Böhlen P., Esch F., Shibasaki T., Baird A., Ling N., Guillemin R. Isolation and characterization of a gamma 1-melanotropin-like peptide from bovine neurointermediate pituitary. FEBS Lett. 1981 Jun 1;128(1):67–70. doi: 10.1016/0014-5793(81)81081-2. [DOI] [PubMed] [Google Scholar]
  4. Calogero A. E., Gallucci W. T., Gold P. W., Chrousos G. P. Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications. J Clin Invest. 1988 Sep;82(3):767–774. doi: 10.1172/JCI113677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol. 1987 Aug;7(8):2745–2752. doi: 10.1128/mcb.7.8.2745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chhajlani V., Wikberg J. E. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 1992 Sep 14;309(3):417–420. doi: 10.1016/0014-5793(92)80820-7. [DOI] [PubMed] [Google Scholar]
  7. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  8. Cone R. D., Mountjoy K. G., Robbins L. S., Nadeau J. H., Johnson K. R., Roselli-Rehfuss L., Mortrud M. T. Cloning and functional characterization of a family of receptors for the melanotropic peptides. Ann N Y Acad Sci. 1993 May 31;680:342–363. doi: 10.1111/j.1749-6632.1993.tb19694.x. [DOI] [PubMed] [Google Scholar]
  9. Estivariz F. E., Hope J., McLean C., Lowry P. J. Purification and characterization of a gamma-melanotropin precursor from frozen human pituitary glands. Biochem J. 1980 Oct 1;191(1):125–132. doi: 10.1042/bj1910125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. FERRARI W. Behavioural changes in animals after intracisternal injection with adrenocorticotrophic hormone and melanocyte-stimulating hormone. Nature. 1958 Mar 29;181(4613):925–926. doi: 10.1038/181925a0. [DOI] [PubMed] [Google Scholar]
  11. Feng J. D., Dao T., Lipton J. M. Effects of preoptic microinjections of alpha-MSH on fever and normal temperature control in rabbits. Brain Res Bull. 1987 Apr;18(4):473–477. doi: 10.1016/0361-9230(87)90111-0. [DOI] [PubMed] [Google Scholar]
  12. Frazier A. L., Robbins L. S., Stork P. J., Sprengel R., Segaloff D. L., Cone R. D. Isolation of TSH and LH/CG receptor cDNAs from human thyroid: regulation by tissue specific splicing. Mol Endocrinol. 1990 Aug;4(8):1264–1276. doi: 10.1210/mend-4-8-1264. [DOI] [PubMed] [Google Scholar]
  13. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., Watson S. J., DelValle J., Yamada T. Molecular cloning of a novel melanocortin receptor. J Biol Chem. 1993 Apr 15;268(11):8246–8250. [PubMed] [Google Scholar]
  14. Gilman A. G. A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A. 1970 Sep;67(1):305–312. doi: 10.1073/pnas.67.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gruber K. A., Callahan M. F. ACTH-(4-10) through gamma-MSH: evidence for a new class of central autonomic nervous system-regulating peptides. Am J Physiol. 1989 Oct;257(4 Pt 2):R681–R694. doi: 10.1152/ajpregu.1989.257.4.R681. [DOI] [PubMed] [Google Scholar]
  16. Hnatowich M. R., Queen G., Stein D., LaBella F. S. ACTH receptors in nervous tissue. High affinity binding-sequestration of [125I]Phe2,Nle4]ACTH 1-24 in homogenates and slices from rat brain. Can J Physiol Pharmacol. 1989 Jun;67(6):568–576. doi: 10.1139/y89-091. [DOI] [PubMed] [Google Scholar]
  17. Kawai Y., Inagaki S., Shiosaka S., Shibasaki T., Ling N., Tohyama M., Shiotani Y. The distribution and projection of gamma-melanocyte stimulating hormone in the rat brain: an immunohistochemical analysis. Brain Res. 1984 Apr 9;297(1):21–32. doi: 10.1016/0006-8993(84)90539-0. [DOI] [PubMed] [Google Scholar]
  18. Klein M. C., Hutchins P. M., Lymangrover J. R., Gruber K. A. Pressor and cardioaccelerator effects of gamma MSH and related peptides. Life Sci. 1985 Feb 25;36(8):769–775. doi: 10.1016/0024-3205(85)90197-3. [DOI] [PubMed] [Google Scholar]
  19. Lin S. Y., Chaves C., Wiedemann E., Humphreys M. H. A gamma-melanocyte stimulating hormone-like peptide causes reflex natriuresis after acute unilateral nephrectomy. Hypertension. 1987 Dec;10(6):619–627. doi: 10.1161/01.hyp.10.6.619. [DOI] [PubMed] [Google Scholar]
  20. Ling N., Ying S., Minick S., Guillemin R. Synthesis and biological activity of four gamma-melanotropin peptides derived from the cryuptic region of the adrenocorticotropin/beta-lipotropin precursor. Life Sci. 1979 Nov 12;25(20):1773–1779. doi: 10.1016/0024-3205(79)90481-8. [DOI] [PubMed] [Google Scholar]
  21. Lipton J. M., Glyn J. R. Central administration of peptides alters thermoregulation in the rabbit. Peptides. 1980 Spring;1(1):15–18. doi: 10.1016/0196-9781(80)90029-7. [DOI] [PubMed] [Google Scholar]
  22. MURPHY J. V., MILLER R. E. The effect of adrenocorticotrophic hormone (ACTH) on avoidance conditioning in the rat. J Comp Physiol Psychol. 1955 Feb;48(1):47–49. doi: 10.1037/h0043004. [DOI] [PubMed] [Google Scholar]
  23. Motta M., Mangili G., Martini L. A "short" feedback loop in the control of ACTH secretion. Endocrinology. 1965 Aug;77(2):392–395. doi: 10.1210/endo-77-2-392. [DOI] [PubMed] [Google Scholar]
  24. Probst W. C., Snyder L. A., Schuster D. I., Brosius J., Sealfon S. C. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol. 1992 Jan-Feb;11(1):1–20. doi: 10.1089/dna.1992.11.1. [DOI] [PubMed] [Google Scholar]
  25. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Slominski A., Costantino R., Wortsman J., Paus R., Ling N. Melanotropic activity of gamma MSH peptides in melanoma cells. Life Sci. 1992;50(15):1103–1108. doi: 10.1016/0024-3205(92)90347-r. [DOI] [PubMed] [Google Scholar]
  27. Strand F. L., Kung T. T. ACTH accelerates recovery of neuromuscular function following crushing of peripheral nerve. Peptides. 1980 Summer;1(2):135–138. doi: 10.1016/0196-9781(80)90077-7. [DOI] [PubMed] [Google Scholar]
  28. Suda T., Yajima F., Tomori N., Sumitomo T., Nakagami Y., Ushiyama T., Demura H., Shizume K. Inhibitory effect of adrenocorticotropin on corticotropin- releasing factor release from rat hypothalamus in vitro. Endocrinology. 1986 Jan;118(1):459–461. doi: 10.1210/endo-118-1-459. [DOI] [PubMed] [Google Scholar]
  29. Tatro J. B., Entwistle M. L., Lester B. R., Reichlin S. Melanotropin receptors of murine melanoma characterized in cultured cells and demonstrated in experimental tumors in situ. Cancer Res. 1990 Feb 15;50(4):1237–1242. [PubMed] [Google Scholar]
  30. Tatro J. B. Melanotropin receptors in the brain are differentially distributed and recognize both corticotropin and alpha-melanocyte stimulating hormone. Brain Res. 1990 Dec 17;536(1-2):124–132. doi: 10.1016/0006-8993(90)90016-5. [DOI] [PubMed] [Google Scholar]
  31. van der Hoop R. G., Vecht C. J., van der Burg M. E., Elderson A., Boogerd W., Heimans J. J., Vries E. P., van Houwelingen J. C., Jennekens F. G., Gispen W. H. Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer. N Engl J Med. 1990 Jan 11;322(2):89–94. doi: 10.1056/NEJM199001113220204. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES